The Department of Health and Human Services said it is redirecting funding from what it calls a wasteful Biden-era project on ...

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have new technology ... U.S. Provisional Patent Application Number 62/307,170, filed March 11, 2016, PCT Patent ...

Proposed legislation, should it make its way through Congress, would dismantle the National Institute of Allergy and ...

Researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ... Two older antibiotics that are no longer under patent, clindamycin and ...

This technology is directed towards a potential treatment for a new disease, CHAPLE (Complement Hyperactivation, Angiopathic thrombosis, and Protein-Losing Enteropathy), identified by NIAID ...